2021 |
|
2020 |
- COVID-19 Vaccine IND Approved
- Completed construction of Seongnam GMP Center
-
- Completed phase-1 clinical trial on BVAC-B
- Received approval on phase-1 clinical trial on BVAC-P
|
2019 |
- Signed a contract on Seongnam SK V1 Tower
- Listed in KOSDAQ (February 20)
|
2018 |
- Signed a contract on general industrial complex in Magok
- Won 'Grand Prize for Bio Field' in 4th Korean Company Contest hosted by Moneytoday
- Developed phase-2 clinical trial on BVAC-C : Selected as Health and Medical Service Technology R&D Project by Ministry of Health and Welfare
- Received approval on phase-1 clinical trial on BVAC-B
|
2017 |
- Received approval on phase-2 a clinical trial on BVAC-C
- Developed phase-1 clinical trial on BVAC-B, developed BVAC non-clinically : Selected as Research and Business Technology Development Project by Ministry of Trade, Industry and Energy
|
2016 |
- Completed development of original CeliVax technology
- Applied a patent right for CeliVax
- Developed new convergent-type antigen : Selected as Bio/Medical Technology Development Project by Ministry of Science and ICT
- Received approval on phase-1 clinical trial on BVAC-C
- Developed phase-1 clinical trial on BVAC-C : Selected as Technical Innovative Business Investment Project by Ministry of SMEs and Startups
|
2015 |
- Developed BVAC-B : Selected as Technical Innovation Business Investment Project by Ministry of SMEs and Startups
|
2014 |
- BVAC-C License Out
- Developed BVAC-C non-clinically : Selected as Advanced Medical Technology Development Project by Ministry of Health and Welfare
- Secured a patent ownership for CeliVax
- Established affiliate research center
- Received venture certificate
|
2007 |
- Started development of original CeliVax technology
|
2006 |
- Founded Cellid Co.,Ltd. (December 11st)
|